Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol infusion for prevention of refractory chronic migraine
2011-002825-22Phase 3Active
- Sponsor
- Hospital General Universitario de Alicante
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic migraine comparing Diprivan infusion with Placebo infusion (2 arms). Primary endpoint: Primary efficacy endpoint. Started Nov 2011; status: active.
02
Drugs
propofol
03
Conditions
chronic migraine
Beyond the preview
Go deeper on 2011-002825-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002825-22.